Go Deep
Morepen Laboratories Limited
Morepen Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 20,422 | 46.5 | 5.37 | 0.17 | 119.04 |
| Sep 2026 | 20,517 | 45.6 | 5.41 | 0.17 | 119.88 |
| Sep 2026 | 20,520 | 47.2 | 5.31 | 0.17 | 120.71 |
| Sep 2026 | 20,520 | 47.2 | 5.31 | 0.17 | 120.71 |
| Sep 2026 | 20,520 | 47.0 | 5.31 | 0.17 | 120.71 |
| Sep 2026 | 20,520 | 47.0 | 5.31 | 0.17 | 120.71 |
| Oct 2026 | 19,541 | 52.4 | 5.88 | 0.17 | 133.72 |
| Oct 2026 | 19,980 | 50.6 | 5.70 | 0.17 | 129.55 |
Morepen Laboratories Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 5,701,281,000.0 | 4,847,159,000.0 | 4,841,610,000.0 | 4,115,758,000.0 |
| Net Profit | 563,994,000.0 | 157,446,000.0 | 275,093,000.0 | 408,746,000.0 |
| EPS | 1.0 | 0.3 | 0.5 | 0.8 |
Morepen Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 18,011,307,000.0 | 18,037,348,000.0 | 16,821,343,000.0 | 14,139,548,000.0 | — |
| Net Profit | 948,768,000.0 | 1,180,204,000.0 | 961,599,000.0 | 386,752,000.0 | — |
| EPS | 1.7 | 2.2 | 1.9 | 0.8 | — |
Morepen Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 19,361,201,000.0 | 17,780,993,000.0 | 12,932,051,000.0 | 11,104,951,000.0 | — |
| Total Liabilities | 6,890,303,000.0 | 5,911,418,000.0 | 4,459,789,000.0 | 3,580,474,000.0 | — |
| Total Equity | 12,464,387,000.0 | 11,562,307,000.0 | 8,472,262,000.0 | 7,529,081,000.0 | — |
Owes vs Owns
Morepen Laboratories Limited owed ₹0.36 for every ₹1 it owned in Mar 2026, up from ₹0.32 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.36× | 0.33× | 0.34× | 0.32× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Morepen Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 2.8%Receivables 17.2%Inventory 14.0%Fixed assets (tangible) 28.1%Intangible assets 6.2%Long-term investments 5.2%Other assets 26.5%
How it's funded — Mar 2026
Short-term debt 3.2%Long-term debt 6.9%Payables 16.4%Other liabilities 9.1%Shareholders' equity 64.4%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 54.1 | 138.4 | 16.9 | 21.7 |
| Receivables | 333.1 | 324.8 | 324.9 | 263.2 |
| Inventory | 271.8 | 300.0 | 248.6 | 228.9 |
| Fixed assets (tangible) | 544.3 | 456.9 | 301.3 | 247.7 |
| Intangible assets | 119.2 | 146.7 | 94.4 | 100.2 |
| Long-term investments | 101.3 | 7.2 | 1.3 | 0.0 |
| Other assets | 512.3 | 404.2 | 305.8 | 248.8 |
| Liabilities & equity | ||||
| Short-term debt | 61.1 | 53.6 | 25.6 | 24.2 |
| Long-term debt | 133.6 | 25.8 | 3.4 | 0.9 |
| Payables | 317.2 | 363.3 | 295.0 | 226.9 |
| Other liabilities | 177.1 | 148.4 | 122.0 | 106.0 |
| Shareholders' equity | 1,247.1 | 1,187.0 | 847.2 | 752.4 |
| Net tangible assets | 1,127.3 | 1,009.5 | 752.9 | 652.7 |
Morepen Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 326,420,000.0 | 320,567,000.0 | 733,746,000.0 | -911,706,000.0 | — |
| Investing Activities | -1,234,160,000.0 | -3,215,066,000.0 | -833,002,000.0 | -465,093,000.0 | — |
| Financing Activities | 973,977,000.0 | 2,998,860,000.0 | 52,049,000.0 | 1,435,431,000.0 | — |